CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer - Reungwetwattana, T; Nakagawa, K; Cho, BC (J Clin Oncol, 2018)
et al.